Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Receivables (2024 - 2025)

RenovoRx (RNXT) has disclosed Receivables for 2 consecutive years, with $139000.0 as the latest value for Q4 2025.

  • Quarterly Receivables rose 223.26% to $139000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $139000.0 through Dec 2025, up 223.26% year-over-year, with the annual reading at $139000.0 for FY2025, 223.26% up from the prior year.
  • Receivables hit $139000.0 in Q4 2025 for RenovoRx, down from $169000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $363000.0 in Q2 2025 to a low of $43000.0 in Q4 2024.